Bristol-Myers Squibb net sales rise marginally in third quarter
By New Statesman - 27 October 11:54

BioPharma company reports $4.8bn net sales.

Glaxo agrees to pay $750m for manufacturing lapses
By New Statesman - 27 October 11:48

Pharmaceutical giant pays US authorities in relation to misidentified products.

Digital River Q3 revenue down 15 per cent to $85m
By New Statesman - 26 October 11:40

Loss comes since to loss of a major client, according to CEO.

Standard Homeopathic to voluntarily recall Hyland's Teething Tablets
By New Statesman - 25 October 12:41

FDA warns of adverse effects in children consistent with belladona toxicity.

Abbott Q3 net sales up 11.8%
By New Statesman - 21 October 13:28

Pharmaceutical giant reports $8.86 billion net sales

Prolong Pharma secures funding for anemia treatment
By New Statesman - 15 October 13:20

Private investor group commits £30m.

Genmab, H Lundbeck sign antibody development agreement
By New Statesman - 15 October 13:12

Genmab to create new human antibodies for central nervous system disorders.

Ortho Biotech releases important new study results
By New Statesman - 15 October 13:05

Prostate cancer research shows promise.

Accellion: Secure File Transfer speeds up collaboration efforts in pharma industry
By New Statesman - 15 October 12:59

Secure File Transfer combines ease of use with regulation standard security and tracking.

ImmunoCellular develops new ICT-107 manufacturing method
By New Statesman - 15 October 12:53

Dendritic cell-based vaccine for treatment of glioblastoma multiforme.

OFT looking into monopoly allegation in private healthcare
By New Statesman - 12 October 16:52

New providers complain of barriers to competition.

US Cancer Institute awards $3m grant to develop automatic detection system
By New Statesman - 12 October 11:59

Three-year grant will help aid detection and characterisation of tumour cells.

Symantec launches new security offering for SMBs
By New Statesman - 07 October 12:43

Security company's new offering designed to safeguard endpoint systems with a single solution manage

Aoxing Pharma revenue falls in FY2010
By New Statesman - 05 October 12:32

Revenue fell from $8.94m to $6.12m from 2009 to 2010.

Bohai Pharma revenue increases 20% for FY2010
By New Statesman - 29 September 11:56

Income from operations was $12.8m for the full year ended 30 June 2010.

Sun Pharma takes over controlling stake in Taro
By New Statesman - 22 September 15:42

Taro manufactures topical creams and ointments.

Polydex Pharma sales decline in Q2
By New Statesman - 16 September 13:26

Polydex reported sales of $986,349, against $1.23m in 2009.

AstraZeneca and University College London in stem cell research partnership
By New Statesman - 13 September 14:45

The new partnership is intended to develop diabeties medicine.

Aceto Q4 net sales up 41.4%
By New Statesman - 13 September 12:32

Sourcing, quality assurance, regulatory support, marketing and distribution company say economy "sti

Novartis led collaboration discovers treatment for drug resistant malaria
By New Statesman - 06 September 11:59

New drug effective against both common strains of the malaria parasite.

Botox-maker to pay $600m settlement for ‘misleading’ promotion
By New Statesman - 02 September 13:43

Settlement follows a US federal investigation.

Genentech gets Refuse to File letter for T-DM1 BLA
By New Statesman - 30 August 16:38

T-DM1 had demonstrated decreased tumors in one-third of female breast cancer sufferers in previous t

Boehringer Ingelheim opens new CoC in Shanghai
By New Statesman - 30 August 16:33

The centre is part of the company's €100m expansion project in China

Novartis Tasigna receives Swissmedic approval
By New Statesman - 30 August 16:31

New drug will allow treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid le

Basilea selects Actelion to distribute Toctino in Canada
By New Statesman - 30 August 16:28

Actelion is entitled to pay a sum of an upfront and milestone payments of C$3.7m to Basilea

Novartis Pharma Tekamlo gets FDA approval
By New Statesman - 30 August 16:25

Novartis Pharma has received the go ahead for new blood pressure drug

Alliance Medical and Priory to be sold
By New Statesman - 25 August 14:37

Failed flotation attempts and search for long-term stability prompt sale of UK medical groups

Taro Pharma net sales rise in Q2
By New Statesman - 24 August 12:35

Net sales rise slightly to $97.97m, while gross profits fall to $56.6m

China BCT revenues increase in Q2
By New Statesman - 17 August 12:40

China BCT has seen a revenue increase of 43 per cent.

Bioanalytical Systems reports rises in quarter three revenue
By New Statesman - 16 August 13:41

Bioanalytical Systems has reported a net income rise for quarter 3 of 2010